The real-world effectiveness of fluvoxamine therapy in mild to moderate COVID-19 patients; A historical cohort study (Fluvoxa Trial)

Background: Fluvoxamine (FVX) has been proposed as a potential treatment for severe COVID-19 by the σ-1 receptor agonist, which can reduce cytokine production. However, the efficacy of FVX remains controversial. Methods: A historical retrospective cohort study was conducted in mild to moderate COVID...

Olles dieđut

Furkejuvvon:
Bibliográfalaš dieđut
Váldodahkkit: Taweegrit Siripongboonsitti (Dahkki), Kriangkrai Tawinprai (Dahkki), Paruspak Payoong (Dahkki), Nithi Mahanonda (Dahkki)
Materiálatiipa: Girji
Almmustuhtton: Elsevier, 2023-12-01T00:00:00Z.
Fáttát:
Liŋkkat:Connect to this object online.
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!

Interneahtta

Connect to this object online.

3rd Floor Main Library

oažžasuvvan: 3rd Floor Main Library
Hildobáiki: A1234.567
Njađus 1 Oažžumis